Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001140361-25-011212
Filing Date
2025-03-31
Accepted
2025-03-31 10:29:57
Documents
20
Period of Report
2025-05-14

Document Format Files

Seq Description Document Type Size
1 PRE 14A ny20043685x771_pre14a.htm   iXBRL PRE 14A 2036178
5 logo_cytokinetics-pms.jpg GRAPHIC 13475
6 ny20043685x771_board.jpg GRAPHIC 209586
7 ny20043685x771_pc01.jpg GRAPHIC 800656
8 ny20043685x771_pc02.jpg GRAPHIC 665359
  Complete submission text file 0001140361-25-011212.txt   7712751

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION - SCHEMA cytk-20250514.xsd EX-101.SCH 2632
3 INLINE XBRL TAXONOMY EXTENSION - LABEL LINKBASE cytk-20250514_lab.xml EX-101.LAB 1512
4 INLINE XBRL TAXONOMY EXTENSION - PRESENTATION LINKBASE cytk-20250514_pre.xml EX-101.PRE 1846
22 EXTRACTED XBRL INSTANCE DOCUMENT ny20043685x771_pre14a_htm.xml XML 451303
Mailing Address 350 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 350 OYSTER POINT BOULEVARD . SOUTH SAN FRANCISCO CA 94080 (650) 624-3000
CYTOKINETICS INC (Filer) CIK: 0001061983 (see all company filings)

EIN.: 943291317 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-50633 | Film No.: 25789836
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)